GENERICUS, INC.
GLEN ALLEN, VA

GENERICUS, INC. is a corporation registered in the state of Florida with the company type FORP (Foreign Profit Corporation). The company was incorporated on October 03, 2017, and it filed under the number F17000004443. Its mailing address is located at 4860 Cox Road, Glen Allen, VA, 23060, United States. As a foreign entity operating in Florida, GENERICUS, INC.'s principal business focuses include providing pharmaceutical products such as Tobramycin Inhalation Solution Pak. Tobramycin Inhalation Solution Pak is noted for certain significant health considerations that patients should discuss with their healthcare providers before usage. Individuals are advised to inform their providers of any history of hearing problems, kidney issues, muscle weakness (such as myasthenia gravis or Parkinson’s disease), breathing difficulties, or prior organ transplants before taking this medication. Pregnant women, those planning to become pregnant, breastfeeding mothers, or individuals who plan to breastfeed should also consult healthcare professionals because the effects on unborn babies cannot be determined. It is important for patients and caregivers to communicate with their doctors regarding all other medications they are taking while using Tobramycin Inhalation Solution Pak due to potential serious interactions. The inhalation solution can lead to severe side effects including ototoxicity (hearing loss), nephrotoxicity (worsening kidney function), muscle weakness exacerbation, neonatal harm, and significant respiratory issues. Regular monitoring of kidney health via blood and urine testing may be required. Common side effects associated with Tobramycin Inhalation Solution Pak are coughing spells; sore throat; productive coughs; shortness of breath; hemoptysis (coughing up blood), exacerbated lung or cystic fibrosis conditions, voice changes like hoarseness; altered taste sensations; and rashes. Patients should promptly report any concerning side effects to their health care providers. The company has undergone its latest annual reporting on February 7, 2024 for the fiscal year 2023-2024. The company's leadership consists of President Juergen Mueller, Vice President Lisa Cambridge, and Secretary Patrick D Ridder. For further information about GENERICUS, INC., visit their official website at genericus.com.